| Item Type | Name |
|
Concept
|
Substance Withdrawal Syndrome
|
|
Concept
|
Syndrome
|
|
Concept
|
Metabolic Syndrome
|
|
Concept
|
Acute Coronary Syndrome
|
|
Concept
|
Cardio-Renal Syndrome
|
|
Academic Article
|
Renal components of the hypertensive syndrome.
|
|
Academic Article
|
Management of hypertension in the cardiometabolic syndrome and diabetes.
|
|
Academic Article
|
The efficacy and safety of low- and high-dose fixed combinations of irbesartan/hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: the INCLUSIVE trial.
|
|
Academic Article
|
The cardiometabolic syndrome and calcium channel blocker combination drugs.
|
|
Academic Article
|
Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome.
|
|
Academic Article
|
Challenges to the diagnosis, evaluation, treatment, and management of clustered cardiometabolic risk factors.
|
|
Academic Article
|
Risk factor assessment for new onset diabetes: literature review.
|
|
Academic Article
|
Current perspectives on hypertension and metabolic syndrome.
|
|
Academic Article
|
Cardiometabolic syndrome and chronic kidney disease: what is the link?
|
|
Academic Article
|
Gender disparity in outcomes of care and management for diabetes and the metabolic syndrome.
|
|
Academic Article
|
Antihypertensive efficacy of Irbesartan/HCTZ in men and women with the metabolic syndrome and type 2 diabetes.
|
|
Academic Article
|
Racial differences in kidney function among individuals with obesity and metabolic syndrome: results from the Kidney Early Evaluation Program (KEEP).
|
|
Academic Article
|
EXamination of cArdiovascular outcoMes with alogliptIN versus standard of carE in patients with type 2 diabetes mellitus and acute coronary syndrome (EXAMINE): a cardiovascular safety study of the dipeptidyl peptidase 4 inhibitor alogliptin in patients with type 2 diabetes with acute coronary syndrome.
|
|
Academic Article
|
Effects of combining simvastatin with rosiglitazone on inflammation, oxidant stress and ambulatory blood pressure in patients with the metabolic syndrome: the SIROCO study.
|
|
Academic Article
|
Clonidine for opiate withdrawal in the chronic pain patient.
|
|
Academic Article
|
The use of clonidine for management of opiate abstinence in a chronic pain patient.
|
|
Academic Article
|
Reversal of diuretic-associated impaired glucose tolerance and new-onset diabetes: results of the STAR-LET study.
|
|
Academic Article
|
Evaluating the cardiovascular effects of the thiazolidinediones and their place in the management of type 2 diabetes in relation to the metabolic syndrome.
|
|
Academic Article
|
Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES).
|
|
Academic Article
|
The role of vasodilating beta-blockers in patients with hypertension and the cardiometabolic syndrome.
|
|
Academic Article
|
The kidney and cardiovascular risk--implications for management: a consensus statement from the European Society of Hypertension.
|
|
Academic Article
|
Insulin resistance, hyperinsulinemia, and hypertension: an epidemiologic approach.
|
|
Academic Article
|
The Association between Parathyroid Hormone Levels and the Cardiorenal Metabolic Syndrome in Non-Diabetic Chronic Kidney Disease.
|
|
Academic Article
|
Alogliptin after acute coronary syndrome in patients with type 2 diabetes.
|
|
Academic Article
|
Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial.
|
|
Academic Article
|
Ischemic cardiac outcomes and hospitalizations according to prior macrovascular disease status in patients with type 2 diabetes and recent acute coronary syndrome from the Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care trial.
|
|
Academic Article
|
Cardiovascular Mortality in Patients With Type 2 Diabetes and Recent Acute Coronary Syndromes From the EXAMINE Trial.
|
|
Academic Article
|
Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor Alogliptin.
|
|
Academic Article
|
Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trial.
|
|
Academic Article
|
Serial Measurement of High-Sensitivity Troponin I and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus in the EXAMINE Trial (Examination of Cardiovascular Outcomes With Alogliptin Versus Standard of Care).
|
|
Academic Article
|
High-sensitivity C-reactive protein, low-density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE (Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care) trial.
|
|
Academic Article
|
Early and Chronic Dipeptidyl-Peptidase-IV Inhibition and Cardiovascular Events in Patients With Type 2 Diabetes Mellitus After an Acute Coronary Syndrome: A Landmark Analysis of the EXAMINE Trial.
|
|
Academic Article
|
Relation of Serum and Urine Renal Biomarkers to Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Recent Acute Coronary Syndromes (From the EXAMINE Trial).
|
|
Academic Article
|
Kidney Biomarkers and Decline in eGFR in Patients with Type 2 Diabetes.
|
|
Academic Article
|
Clinical and Biomarker Predictors of Expanded Heart Failure Outcomes in Patients With Type 2 Diabetes Mellitus After a Recent Acute Coronary Syndrome: Insights From the EXAMINE Trial.
|
|
Academic Article
|
Timing of randomization after an acute coronary syndrome in patients with type 2 diabetes mellitus.
|
|
Academic Article
|
Influence of sex, age and race on coronary and heart failure events in patients with diabetes and post-acute coronary syndrome.
|
|
Academic Article
|
Body weight changes in patients with type 2 diabetes and a recent acute coronary syndrome: an analysis from the EXAMINE trial.
|
|
Academic Article
|
Blood and Urine Biomarkers Predicting Worsening Kidney Function in Patients with Type 2 Diabetes Post-Acute Coronary Syndrome: An Analysis from the EXAMINE Trial.
|
|
Academic Article
|
External validation and extension of the TIMI risk score for heart failure in diabetes for patients with recent acute coronary syndrome: An analysis of the EXAMINE trial.
|
|
Academic Article
|
Aldosterone excess and cardiorenal risk: more common than appreciated.
|
|
Academic Article
|
Pathophysiological Sex Differences in Heart Failure Progression After Acute Coronary Syndrome: Insights From the EXAMINE Trial.
|